Both in Biotechnology
ADMA Biologics vs Vericel
Over the past year ADMA returned −27.7% and VCEL returned +11.9%; their daily moves had a correlation of 0.22.
ADMA −27.7% VCEL +11.9%Growth of $1, one year, split-adjusted
| Metric | ADMA | VCEL |
|---|---|---|
| Price | $11.11 | $41.09 |
| Market cap | $2.49B | $2.10B |
| Today | +0.45% | +1.43% |
| 1 month | +9.9% | 0.0% |
| 6 months | +8.4% | +11.6% |
| Year to date | −39.1% | +14.1% |
| 1 year | −28.2% | +17.2% |
| Revenue growth (YoY) | +2.0% | +22.5% |
| Gross margin | 69.4% | 72.8% |
| Net margin | 30.4% | 2.8% |
| P/E (TTM) | 14.7× | 86.9× |
| Price / sales | 4.9× | 6.9× |
| Net cash | -$60.6M | $162.5M |
| Dividend yield | — | — |
| Volatility (60d) | 38.5% | 32.8% |
| Short % of float | 9.1% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).